לקסיבה

Χώρα: Ισραήλ

Γλώσσα: Εβραϊκά

Πηγή: Ministry of Health

Δραστική ουσία:

FOSAMPRENAVIR AS FOSAMPRENAVIR CALCIUM 700 MG

Διαθέσιμο από:

GLAXO SMITH KLINE (ISRAEL) LTD

Φαρμακολογική κατηγορία (ATC):

J05AE07

Φαρμακοτεχνική μορφή:

TABLETS

Οδός χορήγησης:

PER OS

Κατασκευάζεται από:

GLAXO WELLCOME OPERATION LTD, UK

Θεραπευτική ομάδα:

FOSAMPRENAVIR

Θεραπευτικές ενδείξεις:

Lexiva is indicated in combination with other antiretroviral agents for the treatment of Human Immunodeficiency Virus (HIV) infection in adults. The following points should be considered when initiating therapy with Lexiva/ritonavir in protease inhibitor - experienced patients: - The protease inhibitor - experienced patient study was not large enough to reach a definitive conclusion that Lexiva/ritonavir and lopinavir/ritonavir are clinically equivalent. - Once - daily administration of Lexiva plus ritonvir is not recommended for proteaseinhibitor-experienced patients.

Ημερομηνία της άδειας:

2009-10-01